C4 Therapeutics Total Risk Alpha
| CCCC Stock | | | USD 3.12 -0.47 -13.09% |
C4 Therapeutics total risk alpha lookup summarizes this and related technical indicators for C4 Therapeutics. Some instruments may have limited coverage due to data differences;
Equity Screeners lists screening tools. Use
Trending Equities to better understand diversified portfolio construction. Additional portfolio transparency improves capital positioning. This includes a position in C4 Therapeutics across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in services.
For more information on how to buy CCCC Stock please use our
How to Buy CCCC Stock guide.
C4 Therapeutics has current Total Risk Alpha of 0.7359. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 0.7359 | |
| ER[a] | = | Expected return on investing in C4 Therapeutics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on C4 Therapeutics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
C4 Therapeutics Total Risk Alpha Peers Comparison
CCCC Total Risk Alpha Relative To Other Indicators
C4 Therapeutics is rated
second among stocks in total risk alpha category among its top compatitors. It is currently under evaluation. in maximum drawdown category among its top compatitors reporting about
34.19 of Maximum Drawdown per Total Risk Alpha. The ratio of Maximum Drawdown to Total Risk Alpha for C4 Therapeutics is roughly
34.19 The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.